Meeting
2020 Genitourinary Cancers Symposium
Multicenter comparison of outcomes for clinical and pathologic T3a renal cell carcinoma.
Authors
Aaron Bradshaw
University of California San Diego, La Jolla, CA
Aaron Bradshaw , Fady Ghali , Nathan Miller , Cathrine Keiner , Raksha Dutt , Margaret Meagher , Kendrick Yim , Devin Patel , Robert Guy Uzzo , Brian R. Lane , Umberto Capitanio , Ithaar Derweesh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Other
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 758)
Abstract #
758
Poster Bd #
K14
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Creatinine to cystatin C ratio and mortality in renal cell carcinoma.
First Author: Benjamin Schmeusser
Poster
2023 ASCO Genitourinary Cancers Symposium
Is pathological upstaging to T3a renal cell carcinoma associated with a similar prognosis to non-upstaged pathologic T3a disease? A multicenter analysis.
First Author: Ryan Nasseri
Poster
2022 ASCO Genitourinary Cancers Symposium
Clinicopathologic and survival differences between African Americans and Caucasians with renal cell carcinoma.
First Author: Shirley Wang
Poster
2022 ASCO Genitourinary Cancers Symposium
Long-term follow-up of intravesical gemcitabine and docetaxel as rescue therapy for nonmuscle-invasive bladder cancer.
First Author: Phani T. Chevuru